The BRAF P.V600E Mutation Status of Melanoma Lung Metastases Cannot Be Discriminated on Computed Tomography by LIDC Criteria nor Radiomics Using Machine Learning

Patients with BRAF mutated (BRAF-mt) metastatic melanoma benefit significantly from treatment with BRAF inhibitors. Currently, the BRAF status is determined on archival tumor tissue or on fresh tumor tissue from an invasive biopsy. The aim of this study was to evaluate whether radiomics can predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Angus, Lindsay, Starmans, Martijn P. A., Rajicic, Ana, Odink, Arlette E., Jalving, Mathilde, Niessen, Wiro J., Visser, Jacob J., Sleijfer, Stefan, Klein, Stefan, van der Veldt, Astrid A. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066683/
https://www.ncbi.nlm.nih.gov/pubmed/33915880
http://dx.doi.org/10.3390/jpm11040257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066683/
https://www.ncbi.nlm.nih.gov/pubmed/33915880
http://dx.doi.org/10.3390/jpm11040257

Ejemplares similares